Viking Therapeutics faces higher bar for oral weight-loss drug after strong readout from rival

Date:

Share post:




Viking Therapeutics Inc.’s stock fell 5.6% Friday, in a pullback from recent highs, after strong data from Novo Nordisk on an oral version of its weight-loss drug raised the competitive bar for Viking, which is expected to release data from its oral-drug trial late this quarter.



Source link

Alexandra Williams
Alexandra Williams
Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Recent posts

Related articles

Junior bankers crumble under 90-hour weeks prompting fresh pushback

Investment banks are working their juniors as hard as ever, forcing many into working weeks that stretch...

AMC’s Q1 loss narrows and ‘better times are ahead’ says CEO Adam Aron

AMC Entertainment Holdings Inc. narrowed its loss in the company’s first-quarter results after the bell Wednesday, and...

Airbnb expects a stronger summer quarter, spurred by Olympics, but shares fall

Online vacation-rental platform Airbnb Inc. on Wednesday forecast second-quarter sales that were below Wall Street’s expectations, largely...

Why coffee futures may have already hit their peak for the year

Coffee futures rallied last month, with the benchmark robusta variety climbing to a record and prices for...

Reddit’s first post-IPO results are ‘mission accomplished,’ with international and data-licensing opportunities ahead

Reddit Inc.’s first quarterly results as a public company sent the company’s stock surging on better-than-expected revenue and...

Fed’s Kashkari doesn’t rule out a rate hike

The biggest question facing the U.S. central bank is whether inflation is going to continue to resume...

SECs Gensler slams media for ‘outsized’ focus on crypto

U.S. Securities and Exchange Commission Chair Gary Gensler denied allegations that he is overly focused on the...

Consol Energy sees Baltimore terminal shut through May after bridge collapse

Coal producer Consol Energy Inc. on Tuesday beat analysts’ lowered expectations for its first-quarter profit after the...